dc.contributor.author | Watkins, E.R | |
dc.contributor.author | Scott, J | |
dc.contributor.author | Wingrove, J | |
dc.contributor.author | Rimes, K | |
dc.contributor.author | Bathurst, N | |
dc.contributor.author | Steiner, H | |
dc.contributor.author | Kennell-Webb, S | |
dc.contributor.author | Moulds, M | |
dc.contributor.author | Malliaris, Y | |
dc.date.accessioned | 2013-06-20T12:08:36Z | |
dc.date.issued | 2007-09 | |
dc.description.abstract | The treatment of chronic and recurrent depression is a priority for the development of new interventions. The maintenance of residual symptoms following acute treatment for depression is a risk factor for both chronic depression and further relapse/recurrence. This open case series provides the first data on a cognitive-behavioural treatment for residual depression that explicitly targets depressive rumination. Rumination has been identified as a key factor in the onset and maintenance of depression, which is found to remain elevated following remission from depression. Fourteen consecutively recruited participants meeting criteria for medication--refractory residual depression [Paykel, E.S., Scott, J., Teasdale, J.D., Johnson, A.L., Garland, A., Moore, R. et al., 1999. Prevention of relapse in residual depression by cognitive therapy--a controlled trial. Archives of General Psychiatry 56, 829-835] were treated individually for up to 12 weekly 60-min sessions. Treatment specifically focused on switching patients from less helpful to more helpful styles of thinking through the use of functional analysis, experiential/imagery exercises and behavioural experiments. Treatment produced significant improvements in depressive symptoms, rumination and co-morbid disorders: 71% responded (50% reduction on Hamilton Depression Rating Scale) and 50% achieved full remission. Treating depressive rumination appears to yield generalised improvement in depression and co-morbidity. This study provides preliminary evidence that rumination-focused CBT may be an efficacious treatment for medication--refractory residual depression. | en_GB |
dc.identifier.citation | Behaviour Research and Therapy, 2007, Vol. 45, Issue 9, pp. 2144 - 2154 | en_GB |
dc.identifier.doi | 10.1016/j.brat.2006.09.018 | |
dc.identifier.other | S0005-7967(06)00233-6 | |
dc.identifier.uri | http://hdl.handle.net/10871/11164 | |
dc.language.iso | en | en_GB |
dc.publisher | Elsevier | en_GB |
dc.relation.url | http://www.ncbi.nlm.nih.gov/pubmed/17367751 | en_GB |
dc.subject | Adult | en_GB |
dc.subject | Cognition | en_GB |
dc.subject | Cognitive Therapy | en_GB |
dc.subject | Depressive Disorder | en_GB |
dc.subject | Female | en_GB |
dc.subject | Humans | en_GB |
dc.subject | Male | en_GB |
dc.subject | Middle Aged | en_GB |
dc.subject | Psychiatric Status Rating Scales | en_GB |
dc.subject | Recurrence | en_GB |
dc.subject | Treatment Outcome | en_GB |
dc.title | Rumination-focused cognitive behaviour therapy for residual depression: a case series. | en_GB |
dc.type | Article | en_GB |
dc.date.available | 2013-06-20T12:08:36Z | |
dc.identifier.issn | 0005-7967 | |
exeter.place-of-publication | England | |
dc.description | addresses: Mood Disorders Centre, School of Psychology, University of Exeter, Exeter EX4 4QG, UK. | en_GB |
dc.description | types: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | en_GB |
dc.description | Copyright © 2007 Elsevier. NOTICE: this is the author’s version of a work that was accepted for publication in Journal of Experimental Social Psychology. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published Behaviour Research and Therapy, 2007, Vol. 45, Issue 9, pp. 2144 – 2154 DOI: http://dx.doi.org/10.1016/j.brat.2006.09.018 | en_GB |
dc.identifier.journal | Behaviour Research and Therapy | en_GB |